Cargando…

Determinants of COVID-19 vaccine acceptability among older adults living with HIV

Since the emergency approval of several therapeutic coronavirus disease 2019 (COVID-19) vaccines in the United States, >500 million doses have been administered. However, there have been disparities in vaccine acceptability and uptake. We examined demographic, human immunodeficiency virus (HIV) d...

Descripción completa

Detalles Bibliográficos
Autores principales: Davtyan, Mariam, Frederick, Toinette, Taylor, Jeff, Christensen, Christopher, Brown, Brandon J., Nguyen, Annie L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351509/
https://www.ncbi.nlm.nih.gov/pubmed/35945741
http://dx.doi.org/10.1097/MD.0000000000029907
_version_ 1784762459024785408
author Davtyan, Mariam
Frederick, Toinette
Taylor, Jeff
Christensen, Christopher
Brown, Brandon J.
Nguyen, Annie L.
author_facet Davtyan, Mariam
Frederick, Toinette
Taylor, Jeff
Christensen, Christopher
Brown, Brandon J.
Nguyen, Annie L.
author_sort Davtyan, Mariam
collection PubMed
description Since the emergency approval of several therapeutic coronavirus disease 2019 (COVID-19) vaccines in the United States, >500 million doses have been administered. However, there have been disparities in vaccine acceptability and uptake. We examined demographic, human immunodeficiency virus (HIV) disease, and psychosocial factors associated with COVID-19 vaccine acceptability in older adults (≥50 years) living with HIV in the Coachella Valley, California. Participants completed a 1-time anonymous online questionnaire assessing their demographic (i.e., age, race, education, etc), HIV disease (i.e., viral suppression, years living with HIV, acquired immunodeficiency syndrome diagnosis), psychosocial (i.e., HIV-related stigma, personal mastery, depression, etc) characteristics, and COVID-19 vaccine acceptability. Respondents were offered an electronic $20 United States dollar (USD) gift card for survey completion. Descriptive, univariable, and multivariable tests were conducted to analyze the data. Between September 2020 and February 2021, 114 surveys were completed. Eighty-six (75%) agreed/strongly agreed with the COVID-19 vaccine acceptability statement that they saw no problem with receiving a COVID-19 vaccine if one became available. Among those who agreed/strongly agreed, the mean age was 62.2 years (standard deviation = 7.20); 86% self-identified as White; 95% male; 91% with more than high school education; and 31% with annual income <$20,000 USD. Among respondents who disagreed/strongly disagreed, the mean age was 59.9 years (standard deviation = 4.85); 50% self-identified as White; 50% male; 64% with more than high school education; and 4% with annual income <$20,000 USD. In the univariable analyses, those who disagreed/strongly disagreed with the COVID-19 vaccine acceptability statement were significantly more likely to be living with HIV for fewer years, experiencing higher levels of HIV-related stigma and depression, and with lower levels of personal mastery. In the multivariable logistic regression model, self-identification as female vs male and unemployed vs employed was significantly associated with decreased COVID-19 vaccine acceptability (odds ratio = 0.09, 95% confidence interval: 0.01–0.71 and odds ratio = 0.08, 95% confidence interval: 0.01–0.70 respectively), adjusting for ethnicity, marital status, education, disability, years living with HIV, HIV-related stigma, and depression. Additional studies are needed to understand vaccine-related decision-making among older adults living with HIV. Programmatic efforts may also be necessary to disseminate accurate information/resources about COVID-19 vaccines to those with more recent HIV diagnoses, experiencing HIV-related stigma and depression, with lower levels of personal mastery, and facing socioeconomic disparities.
format Online
Article
Text
id pubmed-9351509
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-93515092022-08-05 Determinants of COVID-19 vaccine acceptability among older adults living with HIV Davtyan, Mariam Frederick, Toinette Taylor, Jeff Christensen, Christopher Brown, Brandon J. Nguyen, Annie L. Medicine (Baltimore) Research Article Since the emergency approval of several therapeutic coronavirus disease 2019 (COVID-19) vaccines in the United States, >500 million doses have been administered. However, there have been disparities in vaccine acceptability and uptake. We examined demographic, human immunodeficiency virus (HIV) disease, and psychosocial factors associated with COVID-19 vaccine acceptability in older adults (≥50 years) living with HIV in the Coachella Valley, California. Participants completed a 1-time anonymous online questionnaire assessing their demographic (i.e., age, race, education, etc), HIV disease (i.e., viral suppression, years living with HIV, acquired immunodeficiency syndrome diagnosis), psychosocial (i.e., HIV-related stigma, personal mastery, depression, etc) characteristics, and COVID-19 vaccine acceptability. Respondents were offered an electronic $20 United States dollar (USD) gift card for survey completion. Descriptive, univariable, and multivariable tests were conducted to analyze the data. Between September 2020 and February 2021, 114 surveys were completed. Eighty-six (75%) agreed/strongly agreed with the COVID-19 vaccine acceptability statement that they saw no problem with receiving a COVID-19 vaccine if one became available. Among those who agreed/strongly agreed, the mean age was 62.2 years (standard deviation = 7.20); 86% self-identified as White; 95% male; 91% with more than high school education; and 31% with annual income <$20,000 USD. Among respondents who disagreed/strongly disagreed, the mean age was 59.9 years (standard deviation = 4.85); 50% self-identified as White; 50% male; 64% with more than high school education; and 4% with annual income <$20,000 USD. In the univariable analyses, those who disagreed/strongly disagreed with the COVID-19 vaccine acceptability statement were significantly more likely to be living with HIV for fewer years, experiencing higher levels of HIV-related stigma and depression, and with lower levels of personal mastery. In the multivariable logistic regression model, self-identification as female vs male and unemployed vs employed was significantly associated with decreased COVID-19 vaccine acceptability (odds ratio = 0.09, 95% confidence interval: 0.01–0.71 and odds ratio = 0.08, 95% confidence interval: 0.01–0.70 respectively), adjusting for ethnicity, marital status, education, disability, years living with HIV, HIV-related stigma, and depression. Additional studies are needed to understand vaccine-related decision-making among older adults living with HIV. Programmatic efforts may also be necessary to disseminate accurate information/resources about COVID-19 vaccines to those with more recent HIV diagnoses, experiencing HIV-related stigma and depression, with lower levels of personal mastery, and facing socioeconomic disparities. Lippincott Williams & Wilkins 2022-08-05 /pmc/articles/PMC9351509/ /pubmed/35945741 http://dx.doi.org/10.1097/MD.0000000000029907 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal.
spellingShingle Research Article
Davtyan, Mariam
Frederick, Toinette
Taylor, Jeff
Christensen, Christopher
Brown, Brandon J.
Nguyen, Annie L.
Determinants of COVID-19 vaccine acceptability among older adults living with HIV
title Determinants of COVID-19 vaccine acceptability among older adults living with HIV
title_full Determinants of COVID-19 vaccine acceptability among older adults living with HIV
title_fullStr Determinants of COVID-19 vaccine acceptability among older adults living with HIV
title_full_unstemmed Determinants of COVID-19 vaccine acceptability among older adults living with HIV
title_short Determinants of COVID-19 vaccine acceptability among older adults living with HIV
title_sort determinants of covid-19 vaccine acceptability among older adults living with hiv
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351509/
https://www.ncbi.nlm.nih.gov/pubmed/35945741
http://dx.doi.org/10.1097/MD.0000000000029907
work_keys_str_mv AT davtyanmariam determinantsofcovid19vaccineacceptabilityamongolderadultslivingwithhiv
AT fredericktoinette determinantsofcovid19vaccineacceptabilityamongolderadultslivingwithhiv
AT taylorjeff determinantsofcovid19vaccineacceptabilityamongolderadultslivingwithhiv
AT christensenchristopher determinantsofcovid19vaccineacceptabilityamongolderadultslivingwithhiv
AT brownbrandonj determinantsofcovid19vaccineacceptabilityamongolderadultslivingwithhiv
AT nguyenanniel determinantsofcovid19vaccineacceptabilityamongolderadultslivingwithhiv